Rare Disease Supporters Suggest Permanent PRV Program, Even If It May Concern FDA
Executive SummaryNon-profit biotech founder says permanent pediatric rare disease priority review voucher program will boost incentive, but FDA is concerned about resource drain vouchers cause.
You may also be interested in...
Medicines Development for Global Health is the first nonprofit to earn a priority review voucher for bringing a neglected tropical disease therapy to US approval. Project carried on research from the Wyeth era.